Touyun Biotech Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	345	716	522	645	1,207	3,704
Market Cap Growth	-28.07%	37.10%	-19.13%	-46.51%	-67.42%	78.05%
Enterprise Value	929	1,262	1,017	1,090	1,623	4,137
Last Close Price	0.12	0.26	0.19	0.23	0.43	1.32
PE Ratio	26.69	26.70	-	-	-	-
PS Ratio	5.15	10.68	5.24	3.25	3.82	13.07
PB Ratio	12.60	26.12	-12.84	30.63	4.26	7.61
P/TBV Ratio	-	-	-	-	4.58	7.89
P/OCF Ratio	-	-	-	295.63	-	-
EV/Sales Ratio	13.87	18.84	10.21	5.49	5.14	14.59
Debt / Equity Ratio	18.72	18.72	-11.85	22.75	1.73	0.85
Net Debt / Equity Ratio	18.44	18.44	-10.04	20.68	1.20	0.64
Net Debt / EBITDA Ratio	-10.55	-10.55	-17.59	-6.10	-11.24	-9.04
Net Debt / FCF Ratio	-16.40	-16.40	-7.61	-29.15	-8.65	-1.43
Asset Turnover	0.11	0.11	0.17	0.27	0.33	0.28
Inventory Turnover	2.37	2.37	3.06	5.69	5.72	5.31
Quick Ratio	0.10	0.10	0.22	0.26	0.53	0.36
Current Ratio	0.17	0.17	0.31	0.43	0.79	0.51
Return on Equity (ROE)	-	-	-	-178.98%	-52.60%	-23.76%
Return on Assets (ROA)	-6.43%	-6.43%	-3.94%	-7.54%	-2.77%	-2.39%
Return on Invested Capital (ROIC)	-11.27%	-13.36%	-8.86%	-16.69%	-5.97%	-5.39%
Return on Capital Employed (ROCE)	-212.90%	-212.90%	476.40%	-39.80%	-8.90%	-7.70%
Earnings Yield	7.76%	3.74%	-16.88%	-41.67%	-16.42%	-1.97%
FCF Yield	-8.92%	-4.30%	-10.28%	-2.32%	-3.26%	-5.87%
Buyback Yield / Dilution	-0.09%	-0.09%	-	-	-0.39%	-4.58%